Jin Medical International Ltd. (ZJYL) — 6-K Filings
All 6-K filings from Jin Medical International Ltd.. Browse 17 Foreign Current Report reports with AI-powered summaries and risk analysis.
6-K Filings (17)
-
Jin Medical International Ltd. Files 6-K Report
— Aug 20, 2025 Risk: low
Jin Medical International Ltd. filed a Form 6-K on August 20, 2025, reporting for the period ending March 31, 2025. The company, incorporated in E9 and headquar -
Jin Medical Starts Production at New Chuzhou Plant
— Jul 16, 2025 Risk: low
Jin Medical International Ltd. announced on July 16, 2025, the commencement of production at Plant No. 3 of its Chuzhou manufacturing facility. This expansion i -
Jin Medical Appoints New Independent Director
— Jun 24, 2025 Risk: low
Jin Medical International Ltd. (Nasdaq: ZJYL) announced on June 24, 2025, the appointment of Dr. James Jiayuan Tong to its board of directors. Dr. Tong will ser -
Jin Medical Director Jourdan Frain Departs
— Jun 17, 2025 Risk: low
Jin Medical International Ltd. announced on June 17, 2025, that Jourdan Frain's term as an Independent Director has concluded. This marks the end of his service -
Jin Medical Gets Nasdaq Listing Deficiency Notice
— May 6, 2025 Risk: high
On May 2, 2025, Jin Medical International Ltd. received a deficiency letter from Nasdaq regarding its continued listing standards. The company is required to su -
Jin Medical International Ltd. Files Form 6-K
— Apr 25, 2025 Risk: low
Jin Medical International Ltd. filed a Form 6-K on April 25, 2025, reporting information for the month of April 2025. The filing includes a press release issued -
Jin Medical Starts New China Manufacturing Facility
— Oct 11, 2024 Risk: low
Jin Medical International Ltd. announced on October 10, 2024, the initiation of a new manufacturing facility in Chuzhou, China. This expansion is detailed in a -
Jin Medical International Ltd. Files 6-K Report
— Jul 26, 2024 Risk: low
Jin Medical International Ltd. filed a Form 6-K on July 26, 2024, reporting as a foreign private issuer. The filing pertains to the period ending March 31, 2024 -
Jin Medical Regains Nasdaq Filing Compliance
— May 14, 2024 Risk: medium
Jin Medical International Ltd. announced on May 14, 2024, that it has regained compliance with Nasdaq's periodic filing requirements. This follows a previous di -
Jin Medical International Ltd. Files 6-K Report
— Apr 12, 2024 Risk: medium
Jin Medical International Ltd. filed a Form 6-K on April 12, 2024, reporting information for April 2024. The filing indicates that DNTW Toronto LLP, the company -
Jin Medical Receives Nasdaq Hearings Panel Decision
— Mar 29, 2024 Risk: medium
Jin Medical International Ltd. (the "Company") announced on March 29, 2024, that it received a Notice of Decision from the Nasdaq Hearings Panel. This follows a -
Jin Medical Regains Nasdaq Public Holder Compliance
— Mar 6, 2024 Risk: low
Jin Medical International Ltd. announced on February 29, 2024, that it has regained compliance with the minimum public holders requirement set by The Nasdaq Sto -
Jin Medical International Ltd. Changes Auditor
— Mar 1, 2024 Risk: medium
Jin Medical International Ltd. announced on February 26, 2024, that DNTW Toronto LLP has resigned as the company's independent registered public accounting firm -
Jin Medical International Faces Nasdaq Delisting Notice
— Feb 23, 2024 Risk: high
Jin Medical International Ltd. received a delisting notice from Nasdaq on December 18, 2023, for failing to provide a required document. This 6-K filing, dated -
Jin Medical Announces 20-for-1 Stock Split Effective Feb 8
— Feb 5, 2024
Jin Medical International Ltd. announced a 20-for-1 stock split, effective February 8, 2024, following shareholder approval on January 30, 2024. This means each -
Jin Medical Appoints Yanru Guo as Independent Director, Audit Chair
— Feb 1, 2024
Jin Medical International Ltd. (NASDAQ: ZJYL) announced on February 1, 2024, the appointment of Yanru Guo as an independent board member and chairperson of its -
Jin Medical Int'l Schedules Extraordinary General Meeting Jan 30
— Jan 11, 2024
Jin Medical International Ltd. (NASDAQ: ZJYL) filed a 6-K on January 11, 2024, announcing an Extraordinary General Meeting (EGM) of shareholders to be held on J
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX